Avantor Inc (AVTR) Stock Price News - Google Finance Avantor, Inc is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania Established in 1904 as J T Baker, the company changed its name to
Avantor (AVTR) Stock Price Overview A detailed overview of Avantor, Inc (AVTR) stock, including real-time price, chart, key statistics, news, and more
Avantor (AVTR) Stock Price, News Analysis - MarketBeat Avantor has a consensus price target of $10 82, representing about 28 9% upside from its current price of $8 40 Avantor has only been the subject of 4 research reports in the past 90 days Read more about Avantor's stock forecast and price target
Avantor, Inc. - Investors - Stock Info Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries
Avantor (AVTR): Buy, sell, or hold post Q1 earnings? - MSN Why Do We Think Avantor Will Underperform? Despite the more favorable entry price, we don't have much confidence in Avantor Here are three reasons we avoid AVTR and a stock we'd rather own
Avantor’s 2026 Reset and Split Investor Signals Might Change The Case . . . Earlier in May 2026, Avantor held its annual shareholder meeting, confirmed its board slate and auditor, while its new leadership issued lower than expected 2026 guidance and acknowledged ongoing bioprocessing and operational challenges At the same time, insider share purchases and mixed moves by institutional investors highlight sharply divided confidence in Avantor’s turnaround efforts